首页 > 市场调查报告书 > 医疗设备

医学影像诊断核子医学

市场调查报告书

商品编码

1379012

2023-2028 年按产品类型、应用、最终用途和地区分類的放射性药物市场报告

Radiopharmaceuticals Market Report by Product Type, Application, End Use, and Region 2023-2028

出版日期: 2023年11月02日 | 出版商:

IMARC | 英文 140 Pages | 商品交期: 2-3个工作天内

价格

简介目录图表

抽象的

2022年全球放射性药物市场规模达52亿美元。展望未来， IMARC Group预计到2028年市场规模将达到73亿美元，2022-2028年复合年增长率（CAGR）为5.8%。

放射性药物是包含放射性同位素的独特製剂，用于临床领域的诊断和治疗。这些药物由放射药剂师（专门从事核医学的医疗专业人员）管理。它们以药丸的形式服用或註射到患者体内的静脉或腔内。一旦它们到达目标位置，它们就会释放放射性物质来破坏肿瘤细胞。因此，放射性药物被用来治疗甲状腺癌、脑癌、淋巴瘤和其他类型的扩散到骨骼的癌症。

放射性药物市场趋势：

由于人口老化和不健康的饮食模式，癌症疾病的盛行率不断增加，这是导致全球放射性药物使用不断增加的关键因素。除此之外，诊断中心数量的不断增加也支撑着市场。此外，越来越多的肿瘤学家建议进行疾病靶向癌症治疗，即利用药物来靶向参与癌细胞发育的特定蛋白质和基因，这对整体销售产生了积极影响。此外，使用放射性标记胜肽和单株抗体来诊断和治疗癌性肿瘤，以及医疗保健支出的增加，正在加强市场的成长。预计推动市场成长的其他主要因素包括肿瘤学家越来越多地使用放射性药物来追踪全身的放射性并确定癌细胞的存在，以及日益转向正子断层扫描（PET）和单光子发射电脑断层扫描(SPECT) 扫描。

本报告回答的关键问题

2022年全球放射性药物市场规模有多大？
2023-2028年全球放射性药物市场的预期成长率是多少？
COVID-19 对全球放射性药物市场有何影响？
推动全球放射性药物市场的关键因素是什么？
根据产品类型，全球放射性药物市场的细分情况如何？
根据应用，全球放射性药物市场的细分情况如何？
根据最终用途，全球放射性药物市场的细分情况如何？
全球放射性药物市场的重点区域有哪些？
谁是全球放射性药物市场的主要参与者/公司？

北美洲
- 美国
  - 市场走向
  - 市场预测
- 加拿大
  - 市场走向
  - 市场预测
亚太
- 中国
  - 市场走向
  - 市场预测
- 日本
  - 市场走向
  - 市场预测
- 印度
  - 市场走向
  - 市场预测
- 韩国
  - 市场走向
  - 市场预测
- 澳洲
  - 市场走向
  - 市场预测
- 印尼
  - 市场走向
  - 市场预测
- 其他的
  - 市场走向
  - 市场预测
欧洲
- 德国
  - 市场走向
  - 市场预测
- 法国
  - 市场走向
  - 市场预测
- 英国
  - 市场走向
  - 市场预测
- 义大利
  - 市场走向
  - 市场预测
- 西班牙
  - 市场走向
  - 市场预测
- 俄罗斯
  - 市场走向
  - 市场预测
- 其他的
  - 市场走向
  - 市场预测
拉丁美洲
- 巴西
  - 市场走向
  - 市场预测
- 墨西哥
  - 市场走向
  - 市场预测
- 其他的
  - 市场走向
  - 市场预测
中东和非洲
- 市场走向
- 按国家/地区分類的市场细分
- 市场预测

第 10 章：SWOT 分析

概述
优势
弱点
机会
威胁

第 11 章：价值链分析

第 12 章：波特五力分析

概述
买家的议价能力
供应商的议价能力
竞争程度
新进入者的威胁
替代品的威胁

第 13 章：价格分析

第14章：竞争格局

市场结构
关键参与者
关键参与者简介
- Advanced Accelerator Applications (Novartis AG)
- Bayer AG
- Bracco SpA
- Cardinal Health Inc.
- Curium Pharma
- General Electric Company
- IBA RadioPharma Solutions
- Jubilant Pharma Limited
- Lantheus Medical Imaging Inc
- Nordion Inc. (Sotera Health)
- NTP Radioisotopes SOC Ltd
- PharmaLogic Holdings Corp.
- Siemens AG

简介目录图表

Product Code: SR112023A3906

Abstract

The global radiopharmaceuticals market size reached US$ 5.2 Billion in 2022. Looking forward, IMARC Group expects the market to reach US$ 7.3 Billion by 2028, exhibiting a growth rate (CAGR) of 5.8% during 2022-2028.

Radiopharmaceuticals are unique formulations comprising radioisotopes that are used in clinical areas for diagnosis and therapy. These medicinal drugs are administered by a radio pharmacist, a medical professional who specializes in nuclear medicine. They are taken in the form of a pill or injected into a vein or cavity of the patient's body. Once they reach the targeted location, they release radioactive agents to destroy the tumor cells. As a result, radiopharmaceuticals are used to treat thyroid, brain, lymphoma and other types of cancer that have spread to the bones.

Radiopharmaceuticals Market Trends:

The increasing prevalence of cancerous diseases on account of the rising aging population and unhealthy dietary patterns represent the key factors contributing to the growing use of radiopharmaceuticals across the globe. Apart from this, the escalating number of diagnostic centers is also supporting the market. Moreover, the rising number of oncologists that are suggesting disease-targeted cancer therapy, which utilizes drugs to target specific proteins and genes involved in the development of cancer cells, are positively influencing the overall sales. Furthermore, the use of radiolabeled peptides and monoclonal antibodies for the diagnosis and treatment of cancerous tumors, along with rising healthcare expenditures, is strengthening the market growth. Other major factors anticipated to propel the growth of the market include the increasing use of radiopharmaceuticals by oncologists to track radioactivity throughout the body and determine the presence of cancer cells and the increasing shift towards positron emission tomography (PET) and single-photon emission computerized tomography (SPECT) scans.

Key Market Segmentation:

IMARC Group provides an analysis of the key trends in each sub-segment of the global radiopharmaceuticals market report, along with forecasts at the global, regional and country level from 2023-2028. Our report has categorized the market based on product type, application and end use.

Breakup by Product Type:

Diagnostic Nuclear Medicine

Therapeutic Nuclear Medicine

Breakup by Application:

Oncology

Cardiology

Neurology

Endocrinology

Others

Breakup by End Use:

Hospitals and Clinics

Research Institutes

Diagnostic Centers

Breakup by Region:

North America

United States

Canada

Asia-Pacific

China

Japan

India

South Korea

Australia

Indonesia

Others

Europe

Germany

France

United Kingdom

Italy

Spain

Russia

Others

Latin America

Brazil

Mexico

Others

Middle East and Africa

Competitive Landscape:

The competitive landscape of the industry has also been examined along with the profiles of the key players being Advanced Accelerator Applications (Novartis AG), Bayer AG, Bracco S.p.A., Cardinal Health Inc., Curium Pharma, General Electric Company, IBA RadioPharma Solutions, Jubilant Pharma Limited, Lantheus Medical Imaging Inc, Nordion Inc. (Sotera Health), NTP Radioisotopes SOC Ltd, PharmaLogic Holdings Corp. and Siemens AG.

Key Questions Answered in This Report

1. What was the size of the global radiopharmaceuticals market in 2022?
2. What is the expected growth rate of the global radiopharmaceuticals market during 2023-2028?
3. What has been the impact of COVID-19 on the global radiopharmaceuticals market?
4. What are the key factors driving the global radiopharmaceuticals market?
5. What is the breakup of the global radiopharmaceuticals market based on the product type?
6. What is the breakup of the global radiopharmaceuticals market based on the application?
7. What is the breakup of the global radiopharmaceuticals market based on the end use?
8. What are the key regions in the global radiopharmaceuticals market?
9. Who are the key players/companies in the global radiopharmaceuticals market?

1 Preface

2 Scope and Methodology

2.1 Objectives of the Study
2.2 Stakeholders
2.3 Data Sources
- 2.3.1 Primary Sources
- 2.3.2 Secondary Sources
2.4 Market Estimation
- 2.4.1 Bottom-Up Approach
- 2.4.2 Top-Down Approach
2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

4.1 Overview
4.2 Key Industry Trends

5 Global Radiopharmaceuticals Market

5.1 Market Overview
5.2 Market Performance
5.3 Impact of COVID-19
5.4 Market Forecast

6 Market Breakup by Product Type

6.1 Diagnostic Nuclear Medicine
- 6.1.1 Market Trends
- 6.1.2 Market Forecast
6.2 Therapeutic Nuclear Medicine
- 6.2.1 Market Trends
- 6.2.2 Market Forecast

7 Market Breakup by Application

7.1 Oncology
- 7.1.1 Market Trends
- 7.1.2 Market Forecast
7.2 Cardiology
- 7.2.1 Market Trends
- 7.2.2 Market Forecast
7.3 Neurology
- 7.3.1 Market Trends
- 7.3.2 Market Forecast
7.4 Endocrinology
- 7.4.1 Market Trends
- 7.4.2 Market Forecast
7.5 Others
- 7.5.1 Market Trends
- 7.5.2 Market Forecast

8 Market Breakup by End Use

8.1 Hospitals and Clinics
- 8.1.1 Market Trends
- 8.1.2 Market Forecast
8.2 Research Institutes
- 8.2.1 Market Trends
- 8.2.2 Market Forecast
8.3 Diagnostic Centers
- 8.3.1 Market Trends
- 8.3.2 Market Forecast

9 Market Breakup by Region

9.1 North America
- 9.1.1 United States
  - 9.1.1.1 Market Trends
  - 9.1.1.2 Market Forecast
- 9.1.2 Canada
  - 9.1.2.1 Market Trends
  - 9.1.2.2 Market Forecast
9.2 Asia-Pacific
- 9.2.1 China
  - 9.2.1.1 Market Trends
  - 9.2.1.2 Market Forecast
- 9.2.2 Japan
  - 9.2.2.1 Market Trends
  - 9.2.2.2 Market Forecast
- 9.2.3 India
  - 9.2.3.1 Market Trends
  - 9.2.3.2 Market Forecast
- 9.2.4 South Korea
  - 9.2.4.1 Market Trends
  - 9.2.4.2 Market Forecast
- 9.2.5 Australia
  - 9.2.5.1 Market Trends
  - 9.2.5.2 Market Forecast
- 9.2.6 Indonesia
  - 9.2.6.1 Market Trends
  - 9.2.6.2 Market Forecast
- 9.2.7 Others
  - 9.2.7.1 Market Trends
  - 9.2.7.2 Market Forecast
9.3 Europe
- 9.3.1 Germany
  - 9.3.1.1 Market Trends
  - 9.3.1.2 Market Forecast
- 9.3.2 France
  - 9.3.2.1 Market Trends
  - 9.3.2.2 Market Forecast
- 9.3.3 United Kingdom
  - 9.3.3.1 Market Trends
  - 9.3.3.2 Market Forecast
- 9.3.4 Italy
  - 9.3.4.1 Market Trends
  - 9.3.4.2 Market Forecast
- 9.3.5 Spain
  - 9.3.5.1 Market Trends
  - 9.3.5.2 Market Forecast
- 9.3.6 Russia
  - 9.3.6.1 Market Trends
  - 9.3.6.2 Market Forecast
- 9.3.7 Others
  - 9.3.7.1 Market Trends
  - 9.3.7.2 Market Forecast
9.4 Latin America
- 9.4.1 Brazil
  - 9.4.1.1 Market Trends
  - 9.4.1.2 Market Forecast
- 9.4.2 Mexico
  - 9.4.2.1 Market Trends
  - 9.4.2.2 Market Forecast
- 9.4.3 Others
  - 9.4.3.1 Market Trends
  - 9.4.3.2 Market Forecast
9.5 Middle East and Africa
- 9.5.1 Market Trends
- 9.5.2 Market Breakup by Country
- 9.5.3 Market Forecast

10 SWOT Analysis

10.1 Overview
10.2 Strengths
10.3 Weaknesses
10.4 Opportunities
10.5 Threats

11 Value Chain Analysis

12 Porters Five Forces Analysis

12.1 Overview
12.2 Bargaining Power of Buyers
12.3 Bargaining Power of Suppliers
12.4 Degree of Competition
12.5 Threat of New Entrants
12.6 Threat of Substitutes

13 Price Analysis

14 Competitive Landscape

14.1 Market Structure
14.2 Key Players
14.3 Profiles of Key Players
- 14.3.1 Advanced Accelerator Applications (Novartis AG)
  - 14.3.1.1 Company Overview
  - 14.3.1.2 Product Portfolio
- 14.3.2 Bayer AG
  - 14.3.2.1 Company Overview
  - 14.3.2.2 Product Portfolio
  - 14.3.2.3 Financials
  - 14.3.2.4 SWOT Analysis
- 14.3.3 Bracco S.p.A.
  - 14.3.3.1 Company Overview
  - 14.3.3.2 Product Portfolio
  - 14.3.3.3 SWOT Analysis
- 14.3.4 Cardinal Health Inc.
  - 14.3.4.1 Company Overview
  - 14.3.4.2 Product Portfolio
  - 14.3.4.3 Financials
  - 14.3.4.4 SWOT Analysis
- 14.3.5 Curium Pharma
  - 14.3.5.1 Company Overview
  - 14.3.5.2 Product Portfolio
- 14.3.6 General Electric Company
  - 14.3.6.1 Company Overview
  - 14.3.6.2 Product Portfolio
  - 14.3.6.3 Financials
  - 14.3.6.4 SWOT Analysis
- 14.3.7 IBA RadioPharma Solutions
  - 14.3.7.1 Company Overview
  - 14.3.7.2 Product Portfolio
- 14.3.8 Jubilant Pharma Limited
  - 14.3.8.1 Company Overview
  - 14.3.8.2 Product Portfolio
- 14.3.9 Lantheus Medical Imaging Inc
  - 14.3.9.1 Company Overview
  - 14.3.9.2 Product Portfolio
  - 14.3.9.3 Financials
- 14.3.10 Nordion Inc. (Sotera Health)
  - 14.3.10.1 Company Overview
  - 14.3.10.2 Product Portfolio
  - 14.3.10.3 SWOT Analysis
- 14.3.11 NTP Radioisotopes SOC Ltd
  - 14.3.11.1 Company Overview
  - 14.3.11.2 Product Portfolio
- 14.3.12 PharmaLogic Holdings Corp.
  - 14.3.12.1 Company Overview
  - 14.3.12.2 Product Portfolio
- 14.3.13 Siemens AG
  - 14.3.13.1 Company Overview
  - 14.3.13.2 Product Portfolio
  - 14.3.13.3 Financials
  - 14.3.13.4 SWOT Analysis

简介目录图表

List of Figures

Figure 1: Global: Radiopharmaceuticals Market: Major Drivers and Challenges
Figure 2: Global: Radiopharmaceuticals Market: Sales Value (in Billion US$), 2017-2022
Figure 3: Global: Radiopharmaceuticals Market Forecast: Sales Value (in Billion US$), 2023-2028
Figure 4: Global: Radiopharmaceuticals Market: Breakup by Product Type (in %), 2022
Figure 5: Global: Radiopharmaceuticals Market: Breakup by Application (in %), 2022
Figure 6: Global: Radiopharmaceuticals Market: Breakup by End Use (in %), 2022
Figure 7: Global: Radiopharmaceuticals Market: Breakup by Region (in %), 2022
Figure 8: Global: Radiopharmaceuticals (Diagnostic Nuclear Medicine) Market: Sales Value (in Million US$), 2017 & 2022
Figure 9: Global: Radiopharmaceuticals (Diagnostic Nuclear Medicine) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 10: Global: Radiopharmaceuticals (Therapeutic Nuclear Medicine) Market: Sales Value (in Million US$), 2017 & 2022
Figure 11: Global: Radiopharmaceuticals (Therapeutic Nuclear Medicine) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 12: Global: Radiopharmaceuticals (Oncology) Market: Sales Value (in Million US$), 2017 & 2022
Figure 13: Global: Radiopharmaceuticals (Oncology) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 14: Global: Radiopharmaceuticals (Cardiology) Market: Sales Value (in Million US$), 2017 & 2022
Figure 15: Global: Radiopharmaceuticals (Cardiology) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 16: Global: Radiopharmaceuticals (Neurology) Market: Sales Value (in Million US$), 2017 & 2022
Figure 17: Global: Radiopharmaceuticals (Neurology) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 18: Global: Radiopharmaceuticals (Endocrinology) Market: Sales Value (in Million US$), 2017 & 2022
Figure 19: Global: Radiopharmaceuticals (Endocrinology) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 20: Global: Radiopharmaceuticals (Other Applications) Market: Sales Value (in Million US$), 2017 & 2022
Figure 21: Global: Radiopharmaceuticals (Other Applications) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 22: Global: Radiopharmaceuticals (Hospitals and Clinics) Market: Sales Value (in Million US$), 2017 & 2022
Figure 23: Global: Radiopharmaceuticals (Hospitals and Clinics) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 24: Global: Radiopharmaceuticals (Research Institutes) Market: Sales Value (in Million US$), 2017 & 2022
Figure 25: Global: Radiopharmaceuticals (Research Institutes) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 26: Global: Radiopharmaceuticals (Diagnostic Centers) Market: Sales Value (in Million US$), 2017 & 2022
Figure 27: Global: Radiopharmaceuticals (Diagnostic Centers) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 28: North America: Radiopharmaceuticals Market: Sales Value (in Million US$), 2017 & 2022
Figure 29: North America: Radiopharmaceuticals Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 30: United States: Radiopharmaceuticals Market: Sales Value (in Million US$), 2017 & 2022
Figure 31: United States: Radiopharmaceuticals Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 32: Canada: Radiopharmaceuticals Market: Sales Value (in Million US$), 2017 & 2022
Figure 33: Canada: Radiopharmaceuticals Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 34: Asia-Pacific: Radiopharmaceuticals Market: Sales Value (in Million US$), 2017 & 2022
Figure 35: Asia-Pacific: Radiopharmaceuticals Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 36: China: Radiopharmaceuticals Market: Sales Value (in Million US$), 2017 & 2022
Figure 37: China: Radiopharmaceuticals Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 38: Japan: Radiopharmaceuticals Market: Sales Value (in Million US$), 2017 & 2022
Figure 39: Japan: Radiopharmaceuticals Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 40: India: Radiopharmaceuticals Market: Sales Value (in Million US$), 2017 & 2022
Figure 41: India: Radiopharmaceuticals Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 42: South Korea: Radiopharmaceuticals Market: Sales Value (in Million US$), 2017 & 2022
Figure 43: South Korea: Radiopharmaceuticals Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 44: Australia: Radiopharmaceuticals Market: Sales Value (in Million US$), 2017 & 2022
Figure 45: Australia: Radiopharmaceuticals Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 46: Indonesia: Radiopharmaceuticals Market: Sales Value (in Million US$), 2017 & 2022
Figure 47: Indonesia: Radiopharmaceuticals Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 48: Others: Radiopharmaceuticals Market: Sales Value (in Million US$), 2017 & 2022
Figure 49: Others: Radiopharmaceuticals Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 50: Europe: Radiopharmaceuticals Market: Sales Value (in Million US$), 2017 & 2022
Figure 51: Europe: Radiopharmaceuticals Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 52: Germany: Radiopharmaceuticals Market: Sales Value (in Million US$), 2017 & 2022
Figure 53: Germany: Radiopharmaceuticals Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 54: France: Radiopharmaceuticals Market: Sales Value (in Million US$), 2017 & 2022
Figure 55: France: Radiopharmaceuticals Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 56: United Kingdom: Radiopharmaceuticals Market: Sales Value (in Million US$), 2017 & 2022
Figure 57: United Kingdom: Radiopharmaceuticals Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 58: Italy: Radiopharmaceuticals Market: Sales Value (in Million US$), 2017 & 2022
Figure 59: Italy: Radiopharmaceuticals Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 60: Spain: Radiopharmaceuticals Market: Sales Value (in Million US$), 2017 & 2022
Figure 61: Spain: Radiopharmaceuticals Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 62: Russia: Radiopharmaceuticals Market: Sales Value (in Million US$), 2017 & 2022
Figure 63: Russia: Radiopharmaceuticals Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 64: Others: Radiopharmaceuticals Market: Sales Value (in Million US$), 2017 & 2022
Figure 65: Others: Radiopharmaceuticals Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 66: Latin America: Radiopharmaceuticals Market: Sales Value (in Million US$), 2017 & 2022
Figure 67: Latin America: Radiopharmaceuticals Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 68: Brazil: Radiopharmaceuticals Market: Sales Value (in Million US$), 2017 & 2022
Figure 69: Brazil: Radiopharmaceuticals Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 70: Mexico: Radiopharmaceuticals Market: Sales Value (in Million US$), 2017 & 2022
Figure 71: Mexico: Radiopharmaceuticals Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 72: Others: Radiopharmaceuticals Market: Sales Value (in Million US$), 2017 & 2022
Figure 73: Others: Radiopharmaceuticals Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 74: Middle East and Africa: Radiopharmaceuticals Market: Sales Value (in Million US$), 2017 & 2022
Figure 75: Middle East and Africa: Radiopharmaceuticals Market: Breakup by Country (in %), 2022
Figure 76: Middle East and Africa: Radiopharmaceuticals Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 77: Global: Radiopharmaceuticals Industry: SWOT Analysis
Figure 78: Global: Radiopharmaceuticals Industry: Value Chain Analysis
Figure 79: Global: Radiopharmaceuticals Industry: Porter's Five Forces Analysis

List of Tables

Table 1: Global: Radiopharmaceuticals Market: Key Industry Highlights, 2022 and 2028
Table 2: Global: Radiopharmaceuticals Market Forecast: Breakup by Product Type (in Million US$), 2023-2028
Table 3: Global: Radiopharmaceuticals Market Forecast: Breakup by Application (in Million US$), 2023-2028
Table 4: Global: Radiopharmaceuticals Market Forecast: Breakup by End Use (in Million US$), 2023-2028
Table 5: Global: Radiopharmaceuticals Market Forecast: Breakup by Region (in Million US$), 2023-2028
Table 6: Global: Radiopharmaceuticals Market: Competitive Structure
Table 7: Global: Radiopharmaceuticals Market: Key Players

02-2729-4219

+886-2-2729-4219